1R3

IZOTROPIC CORP.

Healthcare · EUR · F

1R3

Price

€0.148

+0.68%

Cap

€10.14M

Earnings

30d Trend

-3.3%

1R3
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

100% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality35
Momentum44
Technical38
Fundamentals50

Raw weighted: 35×Macro 0.99 (1%)=35

RISK

85/100
90d Volatility
99.5%High
ATR %
6.8%High daily moves
Max Drawdown (1Y)
-63.0%Volatile

QUALITY

35/100
Piotroski F-Score
2/9Weak
Accruals
-603.6%Cash earnings

MOMENTUM

44/100
12-1M Momentum
+2.4%Uptrend
6-1M Momentum
-9.6%Negative
1M Return
-16.4%Sharp decline

TECHNICAL

38/100
RSI (14)
43.3Neutral
Price vs SMA200
-12.9%Bearish trend
MACD
-0.01Bearish momentum
Bollinger Band
-7%Near lower band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.133Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months41
1-5+ years34

Medium-term outlook is neutral — no clear directional thesis

BRAIN47'S ASSESSMENT

I rate IZOTROPIC CORP. at 35/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 50/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

-16.4%

3 MONTHS

+13.0%

12 MONTHS

-14.0%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Medium-term outlook is neutral — no clear directional thesis. Fundamentals (50) and Momentum (44) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 100%. I classify this as a speculative position — elevated volatility at 100% and smaller market cap define the opportunity.

speculativeScore: 35/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.